Incorporation of alpha-fetoprotein(AFP) into subclassification of BCLC C stage hepatocellular carcinoma according to a 5-year survival analysis based on the SEER database-Reference-Cited by-同舟云学术

Incorporation of alpha-fetoprotein(AFP) into subclassification of BCLC C stage hepatocellular carcinoma according to a 5-year survival analysis based on the SEER database

Published:2016-11-09 Issue:49 Volume:7 Page:81389-81401
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhang Nan¹²³,Gu Jiajia²,Yin Li¹²³,Wu Jing²,Du Ming-yu¹²³,Ding Kai²³⁴,Huang Teng¹²³,He Xia¹²³⁴

Affiliation:

1. The Fourth Clinical School of Nanjing Medical University, Nanjing, China

2. Department of Radiation Oncology, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China

3. Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Nanjing, China

4. Xuzhou Medical University, Xuzhou, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Alfa-Fetoprotein as A Staging Determiner of Hepatocellular Carcinoma Progresivity;INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY;2023-07-27

2. Extending Surgical Resection for Hepatocellular Carcinoma Beyond Barcelona Clinic for Liver Cancer (BCLC) Stage A: A Novel Application of the Modified BCLC Staging System;Journal of Hepatocellular Carcinoma;2022-08

3. A comparison of clinical pathologic characteristics between alpha-fetoprotein negative and positive hepatocellular carcinoma patients from Eastern and Southern China;BMC Gastroenterology;2022-04-23

4. Plasma hPG80 (Circulating Progastrin) as a Novel Prognostic Biomarker for Hepatocellular Carcinoma;Cancers;2022-01-13

5. Preparation and in vitro antitumor effects on MDA-MB-231 cells of niclosamide nanocrystals stabilized by poloxamer188 and PBS;International Journal of Pharmaceutics;2020-06